Monsanto’s GM Maize Retreat
ORGANIC, GMO, GENETIC ENGINEERING, 6 Feb 2012
France has held firm in its opposition to Monsanto’s genetically modified MON 810 maize – and the agri-chemical multinational has admitted defeat.
Monsanto had been putting legal pressure on the French government to lift its 2008 cultivation ban on MON 810, firstly with a successful appeal to the European Court of Justice, then with a follow-up case heard in France’s own highest court, the Council of State.
But despite both these institutions ruling that the ban was “insufficiently justified in law”, the French Government, backed by President Sarkozy, has insisted that it will still not allow cultivation of the biotech maize.
Now Monsanto has announced that it would not be selling seeds for MON810 in France this year.
France’s stand – and Monsanto’s capitulation – has been warmly welcomed by anti-GM lobbyists GM Freeze, whose campaign director Pete Riley said: “The decision by Monsanto not to market MON810 seeds in France in 2012 is yet another sign that Monsanto has failed to convince the public or policy makers that there is any benefit to growing to growing GM crops.
“This needs to be acknowledged by industry and politicians and there should be a big shift to agricultural research and development which addresses the future sustainability of farming in Europe. EU policy needs to forget about the bottom line of biotech corporations and focus on developing agro-ecological farming which provides for the needs of farmers, consumers, the environment and future generations.”
Five other EU countries – Germany, Greece, Austria, Luxembourg and Hungary – have current bans on MON810 cultivation in place, and the issue has recently been complicated by another European Court of Justice ruling requiring honey contaminated with GM pollen to be fully authorised as a novel product and labelled as such before it can be sold.
DISCLAIMER: The statements, views and opinions expressed in pieces republished here are solely those of the authors and do not necessarily represent those of TMS. In accordance with title 17 U.S.C. section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. TMS has no affiliation whatsoever with the originator of this article nor is TMS endorsed or sponsored by the originator. “GO TO ORIGINAL” links are provided as a convenience to our readers and allow for verification of authenticity. However, as originating pages are often updated by their originating host sites, the versions posted may not match the versions our readers view when clicking the “GO TO ORIGINAL” links. This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.
Click here to go to the current weekly digest or pick another article:
ORGANIC, GMO, GENETIC ENGINEERING: